Ribbens P H
Int Arch Occup Environ Health. 1985;56(2):75-9. doi: 10.1007/BF00379378.
Vital status and cause of death were assessed for 232 of a group of 233 workers engaged in the manufacturing and formulation of aldrin, dieldrin, endrin and (for a limited period) Telodrin. This group is part of the total exposed population of more than 1000 workers and was selected for follow up on account of the high exposures in the initial years of manufacturing and formulation and of the long exposure (mean 11 years) and observation (mean 24 years) periods. Total observed mortality was 25 versus 38 expected on the basis of the death statistics of the male Dutch population. Of the 9 cancer deaths, 3 were caused by lung cancer, while the remaining 6 were each of a different nature. Although in this group exposures have been high and exposure, as well as observation periods, were long enough for meaningful evaluation, this study revealed no indication of a specific carcinogenic activity of aldrin, dieldrin or endrin in manufacturing plant workers exposed to these products.
对从事艾氏剂、狄氏剂、异狄氏剂以及(在一段有限时期内) Telodrin生产和配制工作的233名工人中的232人评估了生命状态和死因。该组工人是1000多名总暴露人群的一部分,由于在生产和配制的最初几年暴露水平高,且暴露期(平均11年)和观察期(平均24年)长,因此被选作随访对象。观察到的总死亡人数为25人,而根据荷兰男性人口死亡统计预期为38人。在9例癌症死亡病例中,3例由肺癌引起,其余6例性质各异。尽管该组工人的暴露水平高,暴露期和观察期也足够长,足以进行有意义的评估,但本研究未显示出艾氏剂、狄氏剂或异狄氏剂对接触这些产品的工厂工人有特定致癌活性的迹象。